These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4053802)

  • 21. [Clinical significance of the pharmacokinetic determination of theophylline].
    Gao L
    Zhonghua Yi Xue Za Zhi; 1986 Mar; 66(3):137-40, 188. PubMed ID: 3094865
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of a posologic scheme for the continuous intravenous administration of aminophylline].
    Ferrari M; Olivieri M; Padovani R; Angeli S; Dimitri G; Lo Cascio V
    Clin Ter; 1983 Aug; 106(3):175-9. PubMed ID: 6627890
    [No Abstract]   [Full Text] [Related]  

  • 23. Rapid estimation of total body clearance of theophylline in patients receiving intravenous aminophylline infusion.
    Lau AH; O'Connor T; Lam G; Lui CY; Al-Bazzaz FJ; Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):12-5. PubMed ID: 3957483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of oral aminophylline on the result of the immediate intradermal skin test in asthmatic children--its relation to the serum theophylline level].
    Watanabe K
    Arerugi; 1983 Sep; 32(9):960-9. PubMed ID: 6667127
    [No Abstract]   [Full Text] [Related]  

  • 25. [Serum levels and spirometric response with sustained release theophylline].
    Otero MJ; Barrueco M; Mariño EL; Gómez F; de Portugal J; Domínguez-Gil A
    Med Clin (Barc); 1985 Jan; 84(2):51-3. PubMed ID: 3974347
    [No Abstract]   [Full Text] [Related]  

  • 26. [A dose-concentration relationship study in different dosage regimens for theophylline preparations: intravenous for euphylline and peroral for prolonged-action forms].
    Tsoĭ AN; Bogovskiĭ BP; Gavrilenko LN; Kushkenbaeva BE; Kukes VG
    Ter Arkh; 1990; 62(9):22-5. PubMed ID: 2281401
    [No Abstract]   [Full Text] [Related]  

  • 27. [The effect of an oral aminophylline compound with protracted activity on respiratory resistance and blood gases in obstructive respiratory diseases (author's transl)].
    Dorow P
    Arzneimittelforschung; 1978; 28(5):853-6. PubMed ID: 373776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The pharmacodynamics of theophylline (euphylline)].
    Tsoĭ AN; Bogovskiĭ BP; Saprygina TV; Kniazev RM; Titova EV; Kukes VG
    Ter Arkh; 1993; 65(8):36-40. PubMed ID: 8211799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Euphylline suppositories in the treatment of obstructive respiratory tract diseases in childhood].
    Saule H
    Fortschr Med; 1976 Nov; 94(33):1973-8. PubMed ID: 791784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relation of dose, serum concentration and side effects in intravenous aminophylline therapy].
    Katz G; Kewitz G; Vozeh S; Follath F
    Schweiz Med Wochenschr; 1981 Dec; 111(52):2054-6. PubMed ID: 7330656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Theophyllamine. Infusion in patients with acute severe asthma attacks and various loading doses of peroral theophylline].
    Kongerud J; Gulsvik A; Bergmann A; Calmeyer M; Haanaes OC; Selvig K; Bjerve KS
    Tidsskr Nor Laegeforen; 1985 Nov; 105(33):2377-9. PubMed ID: 4082153
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison between effects of aminophylline, proxyphylline and terbutaline in asthmatics.
    Svedmyr K; Mellstrand T; Svedmyr N
    Scand J Respir Dis Suppl; 1977; 101():139-46. PubMed ID: 343235
    [No Abstract]   [Full Text] [Related]  

  • 33. Early estimate of theophylline clearance during intravenous infusion.
    Rizzo A; Mirabella A; Ferrara G; Mangiacavallo A; Bonanno A; Bonsignore G
    Eur J Respir Dis; 1986 Apr; 68(4):291-7. PubMed ID: 3732424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of chronic obstructive pulmonary disease with orally administered aminophylline].
    Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Oct; 11(5):265-8, 317-8. PubMed ID: 3233685
    [No Abstract]   [Full Text] [Related]  

  • 35. Aminophilline suppress the release of chemical mediators in treatment of acute asthma.
    Nakano J; Yano T; Yamamura K; Yoshihara H; Ohbayashi O; Yamashita N; Ohta K
    Respir Med; 2006 Mar; 100(3):542-50. PubMed ID: 16337368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum theophylline levels in asthmatic children after oral administration of a slow-release aminophylline preparation (Phyllocontin Continus tablets).
    McKenzie S; Baillie E
    J Int Med Res; 1979; 7 Suppl 1():22-7. PubMed ID: 437305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Eosinophil cationic protein in serum from adults with asthma and with chronic obstructive pulmonary disease].
    Yoshizawa A; Kamimura M; Sugiyama H; Kudo K; Kabe J
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jan; 34(1):24-9. PubMed ID: 8717287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Aminophylline-retard preparation in the treatment of patients with bronchial asthma].
    Branica S; Vrabec B; Francetić I; Bakran I
    Lijec Vjesn; 1989; 111(9-10):341-3. PubMed ID: 2633012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hemodynamic and therapeutic significance of plasma atrial natriuretic peptide in chronic lung diseases].
    Hiraga T
    Hokkaido Igaku Zasshi; 1991 Mar; 66(2):201-14. PubMed ID: 1829435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of bronchodilating and metabolic effects of intravenous aminophylline and subcutaneous epinephrine individually and in combination in patients with bronchial asthma].
    Kihara N; Makino S
    Arerugi; 1982; 31(7):390-400. PubMed ID: 6295342
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.